Clozapine Tablet, Orally Disintegrating
Product Images NDC 59651-261

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Clozapine (NDC 59651-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Clozapine Fig1)

Figure 1 (Clozapine Fig1)
This text describes a figure showing the cumulative probability of a significant suicide attempt or hospitalization to prevent suicide in patients with schizophrenia or schizoaffective disorder at high risk. The figure includes data points for treatments such as clozapine and olanzipine, and displays the cumulative probability of suicidality over time in months.*
FDA Label Image

Figure-10 (Clozapine Fig10)

Figure-10 (Clozapine Fig10)
This text appears to be information about Clozapine Orally Disintegrating Tablets, including details about the dosage, storage instructions, and the packaging unit. It mentions the tablet containing Clozapine USP 200 mg and provides prescription and dispensing guidance. The tablets are in unit-dose form and may be meant for institutional use only. The text also includes reference numbers and temperature storage recommendations.*
FDA Label Image

Figure-2 (Clozapine Fig2)

Figure-2 (Clozapine Fig2)
This text provides information on Clozapine Orally Disintegrating Tablets with 12.5 mg Clozapine per tablet. The tablets are manufactured by AUROBINDO and are recommended for adults with specific medical conditions. Dosage instructions, storage conditions, and safety precautions are also outlined on the packaging. The product is distributed by Aurobindo Pharma USA and provides a contact address in East Windsor, NJ.*
FDA Label Image

Figure-3 (Clozapine Fig3)

Figure-3 (Clozapine Fig3)
This text provides important information about Clozapine USP 25 mg orally disintegrating tablets distributed by Aurobindo Pharma USA. It includes details such as the manufacturer's address, recommended adult dosage, storage instructions, precautions, and manufacturing location in India. It also emphasizes the importance of keeping the tablets out of reach of children and following the prescribing information.*
FDA Label Image

Figure-4 (Clozapine Fig4)

FDA Label Image

Figure-5 (Clozapine Fig5)

FDA Label Image

Figure-6 (Clozapine Fig6)

Figure-6 (Clozapine Fig6)
This text appears to be information regarding Clozapine Orally Disintegrating Tablets, with a dosage of 100 mg per unit-dose tablet. It also includes storage instructions, dosage guidelines, product details, and dispensing information. The tablets are described as non-child-resistant and intended for adult use only. The text includes a National Drug Code (NDC) number for identification purposes.*
FDA Label Image

Figure-7 (Clozapine Fig7)

Figure-7 (Clozapine Fig7)
This is a prescription medication called Clozapine, which is available in the form of orally disintegrating tablets. Each tablet contains 150 mg of Clozapine USP. It is important to note that the tablets contain Phenylalanine and should be stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F) to protect from moisture. The packaging should be consulted for dosing instructions, and dispensing should be based on ANC results, with quantities dispensed not exceeding limits specified on the full product labeling. The medication is distributed by Aurobindo Pharma USA, Inc., located in New Jersey, with manufacturing in India.*
FDA Label Image

Figure-8 (Clozapine Fig8)

Figure-8 (Clozapine Fig8)
Clozapine orally disintegrating tablets are offered in a pack containing 48 unit-dose tablets, each tablet containing 50 mg of Clozapine USP. These tablets are meant for use in adults and must be kept at a controlled room temperature between 20-25°C. Dispensing of the medication is subject to ANC quantities, and it must not be scaled as per the prescribing information provided in the package. The tablets are non-chewable and not child-resistant, to be used as instructed.*
FDA Label Image

Figure-9 (Clozapine Fig9)

Figure-9 (Clozapine Fig9)
The text provides information about Clozapine Orally Disintegrating Tablets containing 200 mg of Clozapine USP. It is distributed by Aurobindo Pharma USA, Inc. The usual adult dosage, storage instructions, and a caution to keep out of reach of children are also mentioned. The tablets are made in India and contain Phenylalanine. Dispensing should be based on ANC results, with quantities not exceeding the limits in the product labeling.*
FDA Label Image

Chemical Structure (Clozapine Str)

Chemical Structure (Clozapine Str)
This is a chemical compound named Cy5HyCIN with a molecular weight of 326.83. It likely refers to a specific substance used in scientific research or industrial applications.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.